Table 1 Correlation between ALKBH5 expression and clinicopathological features of pancreatic cancer (PC)
Characteristic | No. of patients (%) | ALKBH5 expression | *P | |
|---|---|---|---|---|
Low n = 22 (%) | High n = 20(%) | |||
Age | ||||
 <60 | 20 (47.6) | 12 (54.5) | 8 (40.0) | 0.346 |
 ≥60 | 22 (52.4) | 10 (45.5) | 12 (60.0) |  |
Gender | ||||
 Male | 19 (45.2) | 10 (45.5) | 9 (45.0) | 0.976 |
 Female | 23 (54.8) | 12 (54.5) | 11 (55.0) |  |
Tumor location | ||||
 Head | 29 (69.0) | 15 (68.2) | 14 (70.0) | 0.899 |
 Body/tail | 13 (31.0) | 7 (31.8) | 6 (30.0) |  |
Tumor size | ||||
 ≥3cm | 14 (33.3) | 9 (40.9) | 5 (25.0) | 0.275 |
 <3cm | 28 (66.7) | 13 (59.1) | 15 (75.0) |  |
Differentiation | ||||
 Well to moderate | 28 (66.7) | 11 (50.0) | 17 (85.0) | 0.016* |
 Poor | 14 (33.3) | 11 (50.0) | 3 (15.0) |  |
aTNM stage | ||||
 I | 11 (26.2) | 3 (13.6) | 8 (40.0) | 0.033* |
 II | 17 (40.5) | 8 (36.4) | 9 (45.0) |  |
 III | 14 (33.3) | 11 (50.0) | 3 (15.0) |  |
Vascular invasion | ||||
 Absent | 24 (57.1) | 9 (40.9) | 15 (75.0) | 0.026* |
 Present | 18 (42.9) | 13 (59.1) | 5 (25.0) |  |